Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
American Journal of Nephrology|September 28, 2016
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney DiseaseStuart M Sprague, Paul W Crawford, Joel Z Melnick, et al.Annals of Surgery|July 18, 2022
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal HyperparathyroidismSophie Dream, Lindsay E Kuo, Jennifer H Kuo, et al.Clinical Nephrology|June 8, 2017
Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy dataDaniel W Coyne, Linda H Ficociello, Vidhya Parameswaran, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 19, 2015
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patientsJürgen Floege, Adrian C Covic, Markus Ketteler, et al.American Journal of Nephrology|January 10, 2015
Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney diseaseStuart M Sprague, Arnold L Silva, Fahd Al-Saghir, et al.Kidney International|December 11, 2002
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidismJill S Lindberg, Sharon M Moe, William G Goodman, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HClSharon M Moe, John Cunningham, Jürgen Bommer, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 2015
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by DialysisStuart M Sprague, Ezequiel Bellorin-Font, Vanda Jorgetti, et al.Journal of the American Society of Nephrology : JASN|May 14, 2015
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKDTamara Isakova, Joachim H Ix, Stuart M Sprague, et al.The Journal of Vascular Access|July 2, 2026
Clinical significance of maturing vascular access for incident hemodialysis patientsAndrea Liu, Ryan M Song, Jacob Ryno, et al.Pageof 10